Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement.
Publication
, Journal Article
Aslam, S; Grossi, P; Schlendorf, KH; Holm, AM; Woolley, AE; Blumberg, E; Mehra, MR; working group members,
Published in: The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
May 2020
The advent of therapies for successful treatment of hepatitis C virus has allowed the heart and lung transplant community to re-explore the use of hepatitis C virus-positive donors for organ transplantation, with a benefit for many terminally ill patients. The consensus statements provided herein represent the current state of knowledge and expertise in this area, which we expect will continue to rapidly evolve over the next few years.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
DOI
EISSN
1557-3117
ISSN
1053-2498
Publication Date
May 2020
Volume
39
Issue
5
Start / End Page
418 / 432
Related Subject Headings
- Tissue Donors
- Surgery
- Organ Transplantation
- Humans
- Hepatitis C
- Consensus
- Antiviral Agents
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Aslam, S., Grossi, P., Schlendorf, K. H., Holm, A. M., Woolley, A. E., Blumberg, E., … working group members, . (2020). Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement. The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation, 39(5), 418–432. https://doi.org/10.1016/j.healun.2020.03.004
Aslam, Saima, Paolo Grossi, Kelly H. Schlendorf, Are M. Holm, Ann E. Woolley, Emily Blumberg, Mandeep R. Mehra, and Mandeep R. working group members. “Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement.” The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation 39, no. 5 (May 2020): 418–32. https://doi.org/10.1016/j.healun.2020.03.004.
Aslam S, Grossi P, Schlendorf KH, Holm AM, Woolley AE, Blumberg E, et al. Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation. 2020 May;39(5):418–32.
Aslam, Saima, et al. “Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement.” The Journal of Heart and Lung Transplantation : The Official Publication of the International Society for Heart Transplantation, vol. 39, no. 5, May 2020, pp. 418–32. Epmc, doi:10.1016/j.healun.2020.03.004.
Aslam S, Grossi P, Schlendorf KH, Holm AM, Woolley AE, Blumberg E, Mehra MR, working group members. Utilization of hepatitis C virus-infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement. The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation. 2020 May;39(5):418–432.
Published In
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation
DOI
EISSN
1557-3117
ISSN
1053-2498
Publication Date
May 2020
Volume
39
Issue
5
Start / End Page
418 / 432
Related Subject Headings
- Tissue Donors
- Surgery
- Organ Transplantation
- Humans
- Hepatitis C
- Consensus
- Antiviral Agents
- 1102 Cardiorespiratory Medicine and Haematology